在ICU患者肺部阿斯伯吉洛症的预测模型:一个多中心回顾性队列研究
Yujing Li1,2, Xindie Ren3, Qianqian Wang4
1Department of Critical Care Medicine, The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.
Infection and drug resistance
|January 28, 2025
概括
一个新的模型通过结合临床和微生物学数据来预测侵袭性肺阿斯伯吉洛症 (IPA) 风险. 这种工具有助于在重症肺炎患者中早期发现和管理IPA.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 医学诊断 医学诊断 医学诊断
背景情况:
- 侵袭性肺阿斯伯吉洛症 (IPA) 预测模型经常忽视并发的微生物.
- 确定IPA的风险因素对于在重症监护机构及时干预至关重要.
研究的目的:
- 为IPA开发和验证一种新的风险预测模型.
- 整合临床和微生物学特征,以改善IPA风险评估.
主要方法:
- 在17个中国医疗中心的成年人重症监护室进行了回顾性研究.
- 来自重症肺炎患者的支气管支气管洗液的临床代谢学.
- 多变量逻辑回归分析用于构建和验证风险预测模型.
主要成果:
- 在898名患者中,有100名患者 (11%) 被诊断为IPA.
- 确定了六个独立的风险因素:年龄,免疫抑制,慢性病,结缔组织疾病,肝衰竭和细胞巨乳病毒阳性.
- 模型实现了0.791 (培训) 和0.792 (验证) 的AUC,具有良好的灵敏度和特异性.
结论:
- 使用临床元基因组学,开发了一种新的IPA风险预测模型.
- 该模型有效地整合了微生物学数据,以提高IPA风险分层.
- 开发的模型显示了强大的区分能力和IPA预测的校准.
关键词:
在CAP CAP中,我们可以把它转换为CAP.这就是IPA IPA.临床的元基因组学在社区获得的肺炎.侵袭性肺部阿斯伯吉洛症 (Aspergillosis) 是一种侵袭性肺部阿斯伯吉洛症.微生物特征 微生物特征预测模型 预测模型更多相关视频
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
27.9K
10:30Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms
Published on: May 31, 2024
1.2K
相关概念视频
Pneumonia I: Introduction
205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia III: Complications and Assessment
151
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Pneumonia IV: Management
296
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
